Mei-Ren Pan

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Topics

Cancer Stem Cells

Top Venues

International journal of molecular sciences

Journal of personalized medicine

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yu-Hsuan Hung, Hui-Ching Wang, Mei-Ren Pan, Li-Tzong Chen
Chromatin Remodeling-Related PRDM1 Increases Stomach Cancer Proliferation and Is Counteracted by Bromodomain Inhibitor. Journal of personalized medicine 14 (3) (2024)
Yu-Hsuan Hung, Hui-Ching Wang, Mei-Ren Pan, Li-Tzong Chen
Chromatin Remodeling-Related PRDM1 Increases Stomach Cancer Proliferation and Is Counteracted by Bromodomain Inhibitor. Journal of personalized medicine 14 (3) (2024)
Chia-Yu Kuo, Sin-Hua Moi, Ming-Feng Hou, Chi-Wen Luo, Mei-Ren Pan
Chromatin Remodeling Enzyme Cluster Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Breast Cancer. International journal of molecular sciences 24 (6) (2023)
Chia-Yu Kuo, Sin-Hua Moi, Ming-Feng Hou, Chi-Wen Luo, Mei-Ren Pan
Chromatin Remodeling Enzyme Cluster Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Breast Cancer. International journal of molecular sciences 24 (6) (2023)
Chia-Yu Kuo, Sin-Hua Moi, Ming-Feng Hou, Chi-Wen Luo, Mei-Ren Pan
Chromatin Remodeling Enzyme Cluster Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Breast Cancer. International journal of molecular sciences 24 (6) (2023)
Chieh-Ni Kao, Sin-Hua Moi, Ming-Feng Hou, Chi-Wen Luo, Fang-Ming Chen, Mei-Ren Pan
Correction: Kao et al. RNF8-CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer. J. Pers. Med. 2021, 11 , 655. Journal of personalized medicine 12 (3) (2022)
Mei-Ren Pan, Cheng-Che Wu, Jung-Yu Kan, Qiao-Lin Li, Shu-Jyuan Chang, Chun-Chieh Wu, Chung-Liang Li, Fu Ou-Yang, Ming-Feng Hou, Hon-Kan Yip, Chi-Wen Luo
Correction: Pan et al. Impact of FAK Expression on the Cytotoxic Effects of CIK Therapy in Triple-Negative Breast Cancer. Cancers 2020, 12, 94. Cancers 13 (21) (2021)
Hui-Ching Wang, Leong-Perng Chan, Chun-Chieh Wu, Hui-Hua Hsiao, Yi-Chang Liu, Shih-Feng Cho, Jeng-Shiun Du, Ta-Chih Liu, Cheng-Hong Yang, Mei-Ren Pan, Sin-Hua Moi
Progression Risk Score Estimation Based on Immunostaining Data in Oral Cancer Using Unsupervised Hierarchical Clustering Analysis: A Retrospective Study in Taiwan. Journal of personalized medicine 11 (9) (2021)
Hui-Ching Wang, Meng-Chun Chou, Chun-Chieh Wu, Leong-Perng Chan, Sin-Hua Moi, Mei-Ren Pan, Ta-Chih Liu, Cheng-Hong Yang
Application of the Interaction between Tissue Immunohistochemistry Staining and Clinicopathological Factors for Evaluating the Risk of Oral Cancer Progression by Hierarchical Clustering Analysis: A Case-Control Study in a Taiwanese Population. Diagnostics (Basel, Switzerland) 11 (6) (2021)
Hui-Ching Wang, Leong-Perng Chan, Chun-Chieh Wu, Shu-Jyuan Chang, Sin-Hua Moi, Chi-Wen Luo, Mei-Ren Pan
Silencing DNA Polymerase β Induces Aneuploidy as a Biomarker of Poor Prognosis in Oral Squamous Cell Cancer. International journal of molecular sciences 22 (5) (2021)
Chieh-Ni Kao, Sin-Hua Moi, Ming-Feng Hou, Chi-Wen Luo, Fang-Ming Chen, Mei-Ren Pan
RNF8-CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer. Journal of personalized medicine 11 (7) (2021)
Ming-Chuan Hsu, Mei-Ren Pan, Wen-Chun Hung
Two Birds, One Stone: Double Hits on Tumor Growth and Lymphangiogenesis by Targeting Vascular Endothelial Growth Factor Receptor 3. Cells 8 (3) (2019)
Yu-Hsuan Hung, Ming-Chuan Hsu, Li-Tzong Chen, Wen-Chun Hung, Mei-Ren Pan
Alteration of Epigenetic Modifiers in Pancreatic Cancer and Its Clinical Implication. Journal of clinical medicine 8 (6) (2019)
Hui-Ching Wang, Chia-Lin Chou, Ching-Chieh Yang, Wei-Lun Huang, Yin-Chou Hsu, Chi-Wen Luo, Tzu-Ju Chen, Chien-Feng Li, Mei-Ren Pan
Over-Expression of CHD4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal Cancers Receiving Concurrent Chemoradiotherapy. International journal of molecular sciences 20 (17) (2019)
Mei-Ren Pan, Cheng-Che Wu, Jung-Yu Kan, Qiao-Lin Li, Shu-Jyuan Chang, Chun-Chieh Wu, Chung-Liang Li, Fu Ou-Yang, Ming-Feng Hou, Hon-Kan Yip, Chi-Wen Luo
Impact of FAK Expression on the Cytotoxic Effects of CIK Therapy in Triple-Negative Breast Cancer. Cancers 12 (1) (2019)
Mei-Ren Pan, Ming-Feng Hou, Fu Ou-Yang, Chun-Chieh Wu, Shu-Jyuan Chang, Wen-Chun Hung, Hon-Kan Yip, Chi-Wen Luo
FAK is Required for Tumor Metastasis-Related Fluid Microenvironment in Triple-Negative Breast Cancer. Journal of clinical medicine 8 (1) (2019)
Chi-Wen Luo, I-Ling Hsiao, Jaw-Yuan Wang, Chun-Chieh Wu, Wen-Chun Hung, Yu-Han Lin, Tzu-Yi Chen, Yin-Chou Hsu, Tian-Lu Cheng, Mei-Ren Pan
Cell Motility Facilitated by Mono(2-ethylhexyl) Phthalate via Activation of the AKT-β-Catenin-IL-8 Axis in Colorectal Cancer. Journal of agricultural and food chemistry 66 (37) (2018)
Ming-Chuan Hsu, Mei-Ren Pan, Pei-Yi Chu, Ya-Li Tsai, Chia-Hua Tsai, Yan-Shen Shan, Li-Tzong Chen, Wen-Chun Hung
Protein Arginine Methyltransferase 3 Enhances Chemoresistance in Pancreatic Cancer by Methylating hnRNPA1 to Increase ABCG2 Expression. Cancers 11 (1) (2018)
Hui-Ching Wang, Wen-Chun Hung, Li-Tzong Chen, Mei-Ren Pan
From Friend to Enemy: Dissecting the Functional Alteration of Immunoregulatory Components during Pancreatic Tumorigenesis. International journal of molecular sciences 19 (11) (2018)